These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 27315550)

  • 1. Patient and lesion-specific characteristics predict risk of major adverse cardiovascular events among patients with previous percutaneous coronary intervention undergoing noncardiac surgery.
    Armstrong EJ; Graham L; Waldo SW; Valle JA; Maddox TM; Hawn MT
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):617-627. PubMed ID: 27315550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.
    Hawn MT; Graham LA; Richman JS; Itani KM; Henderson WG; Maddox TM
    JAMA; 2013 Oct; 310(14):1462-72. PubMed ID: 24101118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete Revascularization Is Associated With an Increased Risk for Major Adverse Cardiovascular Events Among Patients Undergoing Noncardiac Surgery.
    Armstrong EJ; Graham LA; Waldo SW; Valle JA; Maddox TM; Hawn MT
    JACC Cardiovasc Interv; 2017 Feb; 10(4):329-338. PubMed ID: 28161261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Coronary Stent Indication With Postoperative Outcomes Following Noncardiac Surgery.
    Holcomb CN; Hollis RH; Graham LA; Richman JS; Valle JA; Itani KM; Maddox TM; Hawn MT
    JAMA Surg; 2016 May; 151(5):462-9. PubMed ID: 26720292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events following percutaneous and surgical coronary revascularisation: Analysis of non-MACE outcomes in the Stent or Surgery (SoS) Trial.
    Roberts EB; Perry R; Booth J; Sigwart U; Stables RH
    Int J Cardiol; 2016 Jan; 202():7-12. PubMed ID: 26372883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry.
    Berger PB; Kleiman NS; Pencina MJ; Hsieh WH; Steinhubl SR; Jeremias A; Sonel A; Browne K; Barseness G; Cohen DJ;
    JACC Cardiovasc Interv; 2010 Sep; 3(9):920-7. PubMed ID: 20850090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous Intervention for Myocardial Infarction After Noncardiac Surgery: Patient Characteristics and Outcomes.
    Parashar A; Agarwal S; Krishnaswamy A; Sud K; Poddar KL; Bassi M; Ellis S; Tuzcu EM; Menon V; Kapadia SR
    J Am Coll Cardiol; 2016 Jul; 68(4):329-38. PubMed ID: 27443427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents.
    Généreux P; Redfors B; Witzenbichler B; Arsenault MP; Weisz G; Stuckey TD; Rinaldi MJ; Neumann FJ; Christopher Metzger D; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Francese DP; Marquis-Gravel G; Mintz GS; Kirtane AJ; Maehara A; Mehran R; Stone GW
    Int J Cardiol; 2017 Mar; 231():61-67. PubMed ID: 28040289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncardiac surgery and bleeding after percutaneous coronary intervention.
    To AC; Armstrong G; Zeng I; Webster MW
    Circ Cardiovasc Interv; 2009 Jun; 2(3):213-21. PubMed ID: 20031718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of coronary artery calcification in percutaneous coronary intervention with paclitaxel-eluting stents: Two-year clinical outcomes of paclitaxel-eluting stents in patients from the ARRIVE program.
    Lee MS; Yang T; Lasala J; Cox D
    Catheter Cardiovasc Interv; 2016 Nov; 88(6):891-897. PubMed ID: 26756859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mid-term outcomes after percutaneous interventions in coronary bifurcations.
    Zimarino M; Briguori C; Amat-Santos IJ; Radico F; Barbato E; Chieffo A; Cirillo P; Costa RA; Erglis A; Gamra H; Gil RJ; Kanic V; Kedev SA; Maddestra N; Nakamura S; Pellicano M; Petrov I; Strozzi M; Tesorio T; Vukcevic V; De Caterina R; Stankovic G;
    Int J Cardiol; 2019 May; 283():78-83. PubMed ID: 30528620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative Cardiovascular Risk of Prior Coronary Stent Implantation Among Patients Undergoing Noncardiac Surgery.
    Mahmoud KD; Sanon S; Habermann EB; Lennon RJ; Thomsen KM; Wood DL; Zijlstra F; Frye RL; Holmes DR
    J Am Coll Cardiol; 2016 Mar; 67(9):1038-1049. PubMed ID: 26940923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention.
    Ang L; Behnamfar O; Palakodeti S; Lin F; Pourdjabbar A; Patel MP; Reeves RR; Mahmud E
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved adverse postoperative outcomes with revised American College of Cardiology/American Heart Association guidelines for patients with cardiac stents.
    Graham LA; Singletary BA; Richman JS; Maddox TM; Itani KM; Hawn MT
    JAMA Surg; 2014 Nov; 149(11):1113-20. PubMed ID: 25188466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy.
    Capodanno D; Rossini R; Musumeci G; Lettieri C; Senni M; Valsecchi O; Angiolillo DJ; Lip GY
    Int J Cardiol; 2015 Nov; 199():319-25. PubMed ID: 26241637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus-eluting stent is superior to paclitaxel-eluting stent for coronary intervention in patients with renal insufficiency: Long-term clinical outcomes.
    Ann SH; Seo SM; Kim PJ; Koh YS; Her SH; Shin DI; Park HJ; Park CS; Lee JM; Kim DB; Chang K; Chung WS; Seung KB
    Cardiol J; 2016; 23(6):637-646. PubMed ID: 27665858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravascular Ultrasound Predictors of Major Adverse Cardiovascular Events After Implantation of Everolimus-eluting Stents for Long Coronary Lesions.
    Lee SY; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Rev Esp Cardiol (Engl Ed); 2017 Feb; 70(2):88-95. PubMed ID: 27789170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative percutaneous coronary intervention in patients undergoing open thoracoabdominal and descending thoracic aneurysm repair.
    Girardi LN; Rabotnikov Y; Avgerinos DV
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):163-8. PubMed ID: 24176270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of major adverse cardiac events in patients with coronary artery disease.
    Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
    BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.